TW289755B - - Google Patents

Info

Publication number
TW289755B
TW289755B TW082109528A TW82109528A TW289755B TW 289755 B TW289755 B TW 289755B TW 082109528 A TW082109528 A TW 082109528A TW 82109528 A TW82109528 A TW 82109528A TW 289755 B TW289755 B TW 289755B
Authority
TW
Taiwan
Application number
TW082109528A
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929224169A external-priority patent/GB9224169D0/en
Priority claimed from GB939302367A external-priority patent/GB9302367D0/en
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Application granted granted Critical
Publication of TW289755B publication Critical patent/TW289755B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
TW082109528A 1992-11-18 1993-11-15 TW289755B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929224169A GB9224169D0 (en) 1992-11-18 1992-11-18 Pharmaceutical compounds
GB939302367A GB9302367D0 (en) 1993-02-06 1993-02-06 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
TW289755B true TW289755B (zh) 1996-11-01

Family

ID=26301995

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082109528A TW289755B (zh) 1992-11-18 1993-11-15

Country Status (16)

Country Link
US (1) US5434160A (zh)
EP (2) EP1004584A3 (zh)
JP (1) JPH06199862A (zh)
KR (1) KR940011465A (zh)
CN (1) CN1040982C (zh)
AU (1) AU668602B2 (zh)
CA (1) CA2103203A1 (zh)
CO (1) CO4130335A1 (zh)
CZ (1) CZ243493A3 (zh)
FI (1) FI103727B1 (zh)
HU (1) HU9303261D0 (zh)
IL (1) IL107627A (zh)
NO (1) NO304890B1 (zh)
NZ (1) NZ250195A (zh)
PL (1) PL301059A1 (zh)
TW (1) TW289755B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9306062D0 (en) * 1993-03-24 1993-05-12 Lilly Industries Ltd Pharmaceutical compounds
FR2795071B1 (fr) * 1999-06-16 2001-07-27 Adir Nouveaux derives de carboxylate de 7-oxo-2,3,7,14- tetrahydro-1h-benzo[b]pyrano[3,2,h] acridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE60008574T2 (de) 1999-11-05 2009-10-01 Cytovia, Inc., San Diego Substituierte 4H-Chromene und Analoga als Caspase-Aktivatoren und Apoptose-Induktoren und deren Verwendung
US7053117B2 (en) 2001-05-16 2006-05-30 Cytovia, Inc. Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
US6858607B1 (en) 2001-05-16 2005-02-22 Cytovia, Inc. 7,8-fused 4H-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
US7015328B2 (en) 2001-05-16 2006-03-21 Cytovia, Inc. Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
US7528164B2 (en) 2002-05-16 2009-05-05 Cytovia, Inc. Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
WO2003096982A2 (en) 2002-05-16 2003-11-27 Cytovia, Inc. Substituted 4h-chromenes, 2h-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof
CN101039690A (zh) 2004-09-09 2007-09-19 霍华德弗洛里实验生理及医药学院 酶抑制剂及其应用
US7843312B2 (en) * 2006-12-12 2010-11-30 Honeywell International Inc. Wireless control of security system with key-operated key fob
WO2009065169A1 (en) 2007-11-19 2009-05-28 Howard Florey Institute Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof
EP2638026B1 (en) * 2010-11-12 2018-07-11 Deutsches Krebsforschungszentrum (DKFZ) Chromene derivatives and their analoga as wnt pathway antagonists
WO2023099589A1 (en) * 2021-12-01 2023-06-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Irap inhibitors for use in the treatment of inflammatory diseases
CN115028643B (zh) * 2022-06-10 2024-03-22 中国药科大学 吡喃并喹啉衍生物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
JPS61502124A (ja) * 1984-05-09 1986-09-25 ジ オ−ストラリアン ナシヨナル ユニヴア−シテイ− 免疫応答の調節方法
JP2631710B2 (ja) * 1988-08-16 1997-07-16 日本ヘキスト・マリオン・ルセル株式会社 ピラノ〔f〕キノリノン誘導体及び該化合物を有効成分とする医薬組成物
US4931221A (en) * 1988-12-30 1990-06-05 Ppg Industries, Inc. Photochromic spiropyran compounds
US5284868A (en) * 1991-10-09 1994-02-08 Eli Lilly And Company Pharmaceutical compounds
GB9306062D0 (en) * 1993-03-24 1993-05-12 Lilly Industries Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
US5434160A (en) 1995-07-18
EP0599514A3 (en) 1994-07-06
JPH06199862A (ja) 1994-07-19
AU5067193A (en) 1994-06-02
FI935065A (fi) 1994-05-19
KR940011465A (ko) 1994-06-21
HU9303261D0 (en) 1994-03-28
FI935065A0 (fi) 1993-11-16
IL107627A0 (en) 1994-02-27
EP1004584A3 (en) 2000-07-05
EP1004584A2 (en) 2000-05-31
CN1040982C (zh) 1998-12-02
CZ243493A3 (en) 1994-06-15
CA2103203A1 (en) 1994-05-19
AU668602B2 (en) 1996-05-09
EP0599514A2 (en) 1994-06-01
NO304890B1 (no) 1999-03-01
NO934145D0 (no) 1993-11-16
CO4130335A1 (es) 1995-02-13
IL107627A (en) 1997-04-15
FI103727B (fi) 1999-08-31
CN1092072A (zh) 1994-09-14
NO934145L (no) 1994-05-19
PL301059A1 (en) 1994-05-30
FI103727B1 (fi) 1999-08-31
NZ250195A (en) 1995-12-21

Similar Documents

Publication Publication Date Title
EP0553034A3 (zh)
TW289755B (zh)
DE9200249U1 (zh)
DE9207193U1 (zh)
DE9305564U1 (zh)
DE9200264U1 (zh)
DE9200034U1 (zh)
DE9200172U1 (zh)
DE9200219U1 (zh)
DE9214753U1 (zh)
DE9200051U1 (zh)
DE9200210U1 (zh)
BR9202713C1 (zh)
DE9200212U1 (zh)
DE9200237U1 (zh)
DE9200169U1 (zh)
DE9200180U1 (zh)
DE9200182U1 (zh)
DE9211488U1 (zh)
DE9200091U1 (zh)
DE9217741U1 (zh)
DE9200032U1 (zh)
DE9200233U1 (zh)
DE9205877U1 (zh)
DE9200042U1 (zh)